AIDS/HIV Vaccine
Finding epitopes of HIV-1 that induce protective antibodies remains a challenge
Published in AIDS Weekly, April 26th, 2004
According to recent research published in the journal Nature Reviews Immunology, "During the past 20 years, the pendulum of opinion in the HIV-1 vaccine field has swung between two extremes, initially favoring the induction of antibodies only, and subsequently favoring the induction of cell-mediated immune responses only. At present, the consensus seems to be that induction of both humoral and cellular immunity by an HIV-1 vaccine will be required to achieve maximum protection.
"One obstacle to the development of an effective HIV-1 vaccine has been the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2004-04-26)
More Articles from AIDS Weekly
- Drug Development
Lavendamycin analogues show promise as HIV reverse transcriptase inhibitors - Drug Development
Plant-derived liminoids exhibit potent antiretroviral activity - HIV/AIDS Enzymology
Intracellular transport of HIV integrase elucidated - HIV/AIDS Proteomics
Nuclear targeting activities of HIV Rev transport signals characterized - HIV/AIDS Therapy
Anti-NeoR6 resistance mutations suggest anti-HIV mechanisms - AIDS/HIV Vaccine
MVA-HIV-1 nef vaccine elicits T-helper cell responses in HIV patients - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
